Efficacies of Sequenced Monotherapies of Mycobacterium avium Lung Infection in Mouse - Top-Institutions - MDSpire

Efficacies of Sequenced Monotherapies of Mycobacterium avium Lung Infection in Mouse

  • By

  • Ruth A Howe

  • Binayak Rimal

  • Jay Khandelwal

  • Chandra M Panthi

  • Gyanu Lamichhane

  • December 19, 2025

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Infectious Diseases
    • Pulmonology
    • Microbiology

  • #2

    National Jewish Health
    National Jewish Health

    Denver, CO

    Key Differentiators

    • Pulmonology
    • Infectious Diseases
    • Immunology

  • #3

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Infectious Diseases
    • Pulmonology
    • Clinical Research

  • #4

    Centers for Disease Control and Prevention (CDC)
    Centers for Disease Control and Prevention (CDC)

    Atlanta, GA

    Key Differentiators

    • Infectious Diseases
    • Epidemiology
    • Microbiology

  • #5

    Massachusetts General Hospital / Harvard Medical School
    Massachusetts General Hospital / Harvard Medical School

    Boston, MA

    Key Differentiators

    • Pulmonology
    • Infectious Diseases
    • Clinical Pharmacology

Original Source(s)

Efficacies of Sequenced Monotherapies of Mycobacterium avium Lung Infection in Mouse

  • by Ruth A Howe, Binayak Rimal, Jay Khandelwal, Chandra M Panthi, Gyanu Lamichhane

  • December 19, 2025

Related Content

Antibiotic Falls Short in Disc-Related Back Pain

A randomized trial found no greater pain reduction vs placebo, but questions remain about patients with type 1 Modic changes.

Clonal Spread and Pathoadaptive Changes of Community-Associated Methicillin-Resistant Staphylococcus aureus in Egypt

Refining Vancomycin Use in Early CDI

A modified dosing approach could reshape recurrence prevention strategies.